Go Pro

Context Therapeutics (CNTX) Earnings Date, Estimates & Call Transcripts

Context Therapeutics logo
$0.47 +0.01 (+3.25%)
As of 12:19 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Context Therapeutics Earnings Summary

Context Therapeutics issued Q2 2026 earnings on August 5, 2026, reporting an EPS of -$0.15, which missed analysts' consensus estimates of -$0.09 by $0.06. With a trailing EPS of -$0.48, Context Therapeutics' earnings are expected to grow next year, from ($0.40) to ($0.38) per share.

Latest Q2
Earnings Date
Aug. 5Estimated
Consensus EPS
(Aug. 5)
-$0.09
Actual EPS
(Aug. 5)
-$0.15 Missed By -$0.06

Q2 2026 Earnings Resources

Get Context Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Context Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

CNTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Context Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20263-$0.14-$0.10-$0.13
Q2 20263-$0.10-$0.09-$0.10
Q3 20263-$0.10-$0.07-$0.08
Q4 20263-$0.13-$0.08-$0.10

Context Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/5/2026Q2 2026-$0.0921-$0.15 -$0.0579-$0.15--
5/6/2026Q1 2026-$0.12-$0.09+$0.03-$0.09--
3/23/2026Q4 2025-$0.11-$0.14 -$0.03-$0.14--
11/5/2025Q3 2025-$0.09-$0.10 -$0.01-$0.10--
8/6/2025Q2 2025-$0.06-$0.09 -$0.03-$0.09--
5/14/2025Q1 2025-$0.05-$0.05--$0.05--
3/20/2025Q4 2024-$0.05-$0.04+$0.01---
11/6/2024--$0.11-$0.22 -$0.11-$0.22--

Context Therapeutics Earnings - Frequently Asked Questions

Context Therapeutics (NASDAQ:CNTX) last announced its quarterly earning data on Wednesday, August 5, 2026. Learn more on CNTX's earnings history.

In the previous quarter, Context Therapeutics (NASDAQ:CNTX) missed the analysts' consensus estimate of ($0.09) by $0.06 with a reported earnings per share (EPS) of ($0.15). Learn more on analysts' earnings estimate vs. CNTX's actual earnings.

Context Therapeutics (NASDAQ:CNTX) has a recorded net income of -$36.12 million. CNTX has generated -$0.48 earnings per share over the last four quarters.

Context Therapeutics' earnings are expected to grow from ($0.40) per share to ($0.38) per share in the next year.


Earnings data for NASDAQ:CNTX is sourced from Fiscal.ai, with the most recent quarter reported on 8/5/2026. New results are added as companies report their earnings.
From Our Partners